Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma

OBJECTIVE: The optimal treatment for vitreoretinal lymphoma (VRL) remains a challenge, as central nervous system (CNS) relapse occurs frequently, leading to the worst impact on survival. We previously proposed combined intravitreal methotrexate and systemic high‐dose methotrexate therapy for this di...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Chieh‐Lung, Yeh, Po‐Ting, Fang, Wei‐Quan, Ma, Wei‐Li, Hou, Hsin‐An, Tsai, Cheng‐Hong, Lin, Chang‐Ping, Tien, Hwei‐Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134364/
https://www.ncbi.nlm.nih.gov/pubmed/36602288
http://dx.doi.org/10.1002/cam4.5609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134364/
https://www.ncbi.nlm.nih.gov/pubmed/36602288
http://dx.doi.org/10.1002/cam4.5609

Ejemplares similares